ReviewAnalytical and bioanalytical chemistry2026
Standard Reference Material (SRM®) 1950 metabolites in frozen human plasma-use, impact, lessons learned, and future perspectives.
Review in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2011, the National Institute of Standards and Technology (NIST), in collaboration with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH), issued Standard Reference Material (SRM)® 1950 Metabolites in Frozen Human Plasma to support metabolomics measurements. This critical review traces the development of SRM 1950 and assesses its use and impact over the past 15 years. To evaluate its impact, we reviewed more than 400 technical papers demonstrating its broad adoption in analytical, metabolomic, and lipidomic research. While SRM 1950 included certified values for selected amino acids, fatty acids, and clinical markers (such as cholesterol, glucose, 25-hydroxyvitamin D, and steroid hormones), its greatest impact has been as a shared material for interlaboratory comparisons and the community-generated consensus or target values established for the broad scope of compounds commonly measured in metabolomic and lipidomic studies. Many studies used SRM 1950 to validate analytical methods against NIST-certified values, while over 50 papers provided extensive qualitative and quantitative characterization and compared their results with interlaboratory consensus values and other studies to assess method and platform performance. The success of SRM 1950 helped to catalyze the development of additional NIST reference materials (RMs) for the "omics" communities and highlighted the potential of existing clinical and environmental matrix SRMs for further untargeted characterization and community reporting. Based on this literature review, we offer recommendations to expand the use and impact of the next generation of SRM 1950 and other SRMs/RMs intended and/or useful for untargeted analyses.
Indexed as
Identifiers
42886233What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.